IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Chloroquine and Hydroxychloroquine: the real saviours of Covid 2019?

Author: RAVICHANDRA RAVI, CHARISHMA CHOWDARY PONUGUBATI, ROOPESH BORUGADDA
Abstract: Pneumonia caused by the novel corona virus in china is rapidly spreading into a life -threatening disease. The world health organization announced it as pandemic crisis. Currently the research is going on about the possible treatment modalities is in the preliminary stage. Chloroquine, an old drug which was used for the treatment of malaria has shown to have evident capability in the treatment of COVID-19 associated pneumonia during the clinical trials performed in China. Various evidences have shown its potential role in the treatment of Covid-19. This rapid communication provides an insight into its pharmacology and its possible role in management of Covid-19.
Keyword: COVID-19; coronavirus; chloroquine; hydroxychloroquine; SARS-CoV-2.
DOI: https://doi.org/10.31838/ijpr/2020.12.04.022
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free